Gossamer Bio GOSS
NASDAQ GOSS
$9.58 +1.15 (+13.64%)
At close: Oct 20, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Total Current Liabilities (2018 - 2026)

Updated

Gossamer Bio (GOSS) posted Total Current Liabilities of $137.78 million for Q2 2026, up 157.1% from $53.59 million a year earlier and up 143.8% from the prior quarter.

Analysis

Gossamer Bio (GOSS) Total Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, Gossamer Bio's Total Current Liabilities came in at $63.44 million, up 40.9% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of 10.4% (FY2020 to FY2025).
  • In prior years, Gossamer Bio's Total Current Liabilities was $45.01 million in FY2024 (-12.8%), $51.6 million in FY2023 (+4.8%), $49.23 million in FY2022 (+23.5%) and $39.86 million in FY2021 (+3.1%).
  • The Q2 2026 figure stands as the highest quarterly Total Current Liabilities in data going back to Q4 2018.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last six quarters, with growth averaging 37.2% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q2 2026, with growth of 157.1%; the weakest was Q3 2023, with a decline of 19.6%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $56.51 million (Q1 2026), $63.44 million (Q4 2025) and $62.12 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 54.90 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 41.64 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 31.55 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 11.02 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 32.65 Bn
10 Gossamer Bio 37.88 Mn -435.52 Mn - 137.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 137.78 Mn
Mar 31, 2026 56.51 Mn
Dec 31, 2025 63.44 Mn
Sep 30, 2025 62.12 Mn
Jun 30, 2025 53.59 Mn
Mar 31, 2025 48.22 Mn
Dec 31, 2024 45.01 Mn
Sep 30, 2024 51.09 Mn
Jun 30, 2024 45.19 Mn
Mar 31, 2024 35.82 Mn
Dec 31, 2023 51.60 Mn
Sep 30, 2023 42.32 Mn
Jun 30, 2023 40.14 Mn
Mar 31, 2023 40.57 Mn
Dec 31, 2022 49.23 Mn
Sep 30, 2022 52.65 Mn
Jun 30, 2022 44.41 Mn
Mar 31, 2022 34.57 Mn
Dec 31, 2021 39.86 Mn
Sep 30, 2021 35.90 Mn
API Access

Gossamer Bio Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=GOSS&period=max&api_key=YOUR_API_KEY